Inflammatory Markers in Type 2 Diabetes
Author Information
Author(s): Flávia Ozorio Pereira, Frode Tânia Silvia Medeiros, Yara Santos
Primary Institution: Governador Celso Ramos Hospital and Federal University of Santa Catarina
Hypothesis
This study aims to evaluate the serum levels of inflammatory markers in type 2 diabetic patients compared to nondiabetic subjects.
Conclusion
The study found that type 2 diabetes patients have higher levels of certain inflammatory markers compared to nondiabetic individuals.
Supporting Evidence
- Diabetic patients had higher levels of TNF-α and triglycerides compared to controls.
- No significant differences in CRP levels between diabetic and control groups.
- Diabetic women showed higher levels of inflammatory markers than diabetic men.
Takeaway
People with type 2 diabetes have more inflammation in their bodies than those without diabetes, even if they are not obese.
Methodology
The study compared inflammatory markers in 39 type 2 diabetes patients and 28 nondiabetic controls, excluding those with obesity or other inflammatory conditions.
Limitations
The study excluded individuals with obesity and other inflammatory diseases, which may limit the generalizability of the findings.
Participant Demographics
39 type 2 diabetes patients (18 males, 21 females) and 28 healthy controls (19 males, 9 females).
Statistical Information
P-Value
P < .05 for several comparisons.
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website